Evidence map›Paper›PMID 30326990›Full record

ArticleAllergy and asthma proceedings2018

Cross-sectional study on Asthma Insights and Management in the Gulf and Russia.

Ashraf Alzaabi, Majdy Idrees, Naser Behbehani, Musa R Khaitov, Kaan Tunceli, Eduardo Urdaneta, Nancy Awad, Mohamed Safwat

Abstract readMulticenter Study
In one paragraph

Article in Allergy and asthma proceedings, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed.

  1. Article
  2. Article
  3. Over-the-counter use of short-acting beta-2 agonists: a systematic review.Journal of pharmaceutical policy and practice · 2023
    Review
  4. Article
  5. Article
  6. Article
  7. Over-prescription of short-acting βAsthma research and practice · 2022
    Article
  8. Review
  9. Review
  10. Article
  11. Perspectives on decisions for treatment and care in severe asthma.The World Allergy Organization journal · 2021
    Review
  12. Atopic dermatitis: A disease "Allergy and asthma proceedings · 2018
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Ashraf AlzaabiFrom the Division of Respirology, Zayed Military Hospital, Abu Dhabi, United Arab Emirates.
Majdy IdreesPulmonary Division, Prince Sultan Military Medical City, Riyadh, Kingdom of Saudi Arabia.
Naser BehbehaniDepartment of Medicine, Kuwait University, Kuwait City, Kuwait.
Musa R KhaitovImmunology Department, National Research Center Institute of Immunology, Federal Medical Biological Agency, Moscow, Russia.
Kaan TunceliCenter for Observational and Real-World Evidence (CORE), Merck & Co., Inc., Kenilworth, New Jersey.
Eduardo UrdanetaGlobal Medical Affairs, Merck & Co. Inc., Kenilworth, New Jersey.
Nancy AwadReal-World & Analytics Solutions, IQVIA, Dubai, United Arab Emirates.
Mohamed SafwatReal-World & Analytics Solutions, IQVIA, Dubai, United Arab Emirates.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

AsthmaCross-Sectional StudiesDisease ManagementFemaleHumansMaleMiddle EastPhenotypePopulation SurveillancePrevalenceRussiaSelf ReportSocioeconomic Factors

Identifiers

PMID30326990
PMCPMC6212633

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.